金安國紀(002636.SZ):4057萬元購置上海松江區房產 用於醫藥事業部的辦公場所
格隆匯5月26日丨金安國紀(002636.SZ)公佈,公司的全資子公司上海國紀電子材料有限公司(“上海國紀”)與上海旭亭置業有限公司(“旭亭置業”)於2020年5月25日簽訂《上海市商品房預售合同》,公司向旭亭置業購置一處房產用於醫藥事業部的辦公場所,總房價為人民幣4057.089萬元。
交易標的為上海市松江區滬亭北路199弄7幢1號5層;建築面積1423.54平方米;房屋類型為辦公。
此次在上海松江區九亭購買的商業房產,鄰近市區,便於商務人才聚集,作為醫藥事業部的辦公場所,有利於人才的吸納、業務的開展以及生活通勤的便利。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.